HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytoprotective effect of recombinant human erythropoietin produced in transgenic tobacco plants.

Abstract
Asialo-erythropoietin, a desialylated form of human erythropoietin (EPO) lacking hematopoietic activity, is receiving increased attention because of its broader protective effects in preclinical models of tissue injury. However, attempts to translate its protective effects into clinical practice is hampered by unavailability of suitable expression system and its costly and limit production from expensive mammalian cell-made EPO (rhuEPO(M)) by enzymatic desialylation. In the current study, we took advantage of a plant-based expression system lacking sialylating capacity but possessing an ability to synthesize complex N-glycans to produce cytoprotective recombinant human asialo-rhuEPO. Transgenic tobacco plants expressing asialo-rhuEPO were generated by stably co-expressing human EPO and β1,4-galactosyltransferase (GalT) genes under the control of double CaMV 35S and glyceraldehyde-3-phosphate gene (GapC) promoters, respectively. Plant-produced asialo-rhuEPO (asialo-rhuEPO(P)) was purified by immunoaffinity chromatography. Detailed N-glycan analysis using NSI-FTMS and MS/MS revealed that asialo-rhuEPO(P) bears paucimannosidic, high mannose-type and complex N-glycans. In vitro cytoprotection assays showed that the asialo-rhuEPO(P) (20 U/ml) provides 2-fold better cytoprotection (44%) to neuronal-like mouse neuroblastoma cells from staurosporine-induced cell death than rhuEPO(M) (21%). The cytoprotective effect of the asialo-rhuEPO(P) was found to be mediated by receptor-initiated phosphorylation of Janus kinase 2 (JAK2) and suppression of caspase 3 activation. Altogether, these findings demonstrate that plants are a suitable host for producing cytoprotective rhuEPO derivative. In addition, the general advantages of plant-based expression system can be exploited to address the cost and scalability issues related to its production.
AuthorsFarooqahmed S Kittur, Mamudou Bah, Stephanie Archer-Hartmann, Chiu-Yueh Hung, Parastoo Azadi, Mayumi Ishihara, David C Sane, Jiahua Xie
JournalPloS one (PLoS One) Vol. 8 Issue 10 Pg. e76468 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24124563 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Proteins
  • Erythropoietin
  • Caspase 3
  • Staurosporine
Topics
  • Animals
  • Caspase 3 (metabolism)
  • Cell Death (drug effects)
  • Cell Line, Tumor
  • Cytoprotection
  • Erythropoietin (biosynthesis, chemistry, pharmacology)
  • Gene Expression
  • Gene Order
  • Genetic Vectors
  • Glycosylation
  • Humans
  • Mice
  • Neurons (drug effects)
  • Phosphorylation (drug effects)
  • Plants, Genetically Modified
  • Recombinant Proteins (biosynthesis, chemistry, pharmacology)
  • Staurosporine (pharmacology)
  • Tandem Mass Spectrometry
  • Tobacco (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: